Skip to main content
. 2015 Oct 1;31(10):961–966. doi: 10.1089/aid.2015.0093

FIG. 1.

FIG. 1.

Effects of pioglitazone (n = 6) versus placebo (n = 7) on hepatic triglyceride (TG) content by MR spectroscopy. Within group comparison of baseline to week 48 is significant for pioglitazone (*p = 0.02), but not placebo (p = 0.6). Between group comparison of change in hepatic TG at 48 weeks is not significant (p = 0.2).